Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anna Mamutova"'
Autor:
Ekaterina Alexeeva, Elizaveta Krekhova, Tatyana Dvoryakovskaya, Ksenia Isaeva, Aleksandra Chomakhidze, Evgeniya Chistyakova, Olga Lomakina, Rina Denisova, Anna Mamutova, Anna Fetisova, Marina Gautier, Dariya Vankova, Ivan Kriulin, Ruslan Saygitov
Publikováno v:
Frontiers in Pediatrics, Vol 11 (2023)
BackgroundA significant number of systemic juvenile idiopathic arthritis (sJIA) patients discontinue biologic disease-modifying antirheumatic drugs (bDMARDs) due to lack of efficacy or safety concerns. Studies of biologic therapy switch regimens in s
Externí odkaz:
https://doaj.org/article/c815f5c7534443638840395b3337e769
Autor:
Ekaterina Alexeeva, Tatyana Dvoryakovskaya, Rina Denisova, Tatyana Sleptsova, Kseniya Isaeva, Alexandra Chomahidze, Anna Fetisova, Anna Mamutova, Alina Alshevskaya, Victor Gladkikh, Andrey Moskalev
Publikováno v:
Pediatrics and Neonatology, Vol 60, Iss 5, Pp 549-555 (2019)
Background: Both the steroid- and NSAID-sparing effects of biologics in juvenile idiopathic arthritis (JIA) treatment are key aspects of the dynamics of patient’s condition. The proper selection of biologics enables maximum treatment effectiveness
Externí odkaz:
https://doaj.org/article/d6663ef927814cb4a36a31502d1e630e
Autor:
Liang Chen, Anna Mamutova, Anna Kozlova, Elena Latysheva, Frolov Evgeny, Tatiana Latysheva, Kirill Savostyanov, Alexander Pushkov, Ilya Zhanin, Elena Raykina, Maria Kurnikova, Irina Mersiyanova, Craig D. Platt, Hyuk Jee, Kailey Brodeur, Yan Du, Meng Liu, Aaron Weiss, Grant S. Schulert, Jackeline Rodriguez-Smith, Michael S. Hershfield, Ivona Aksentijevich, Qing Zhou, Peter A. Nigrovic, Anna Shcherbina, Ekaterina Alexeeva, Pui Y. Lee
Publikováno v:
Journal of Allergy and Clinical Immunology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91db7472918fb7dcaf7cae15565418e1
https://doi.org/10.1016/j.jaci.2023.04.014
https://doi.org/10.1016/j.jaci.2023.04.014
Autor:
Ekaterina Alexeeva, Elizaveta Krekhova, Tatyana Dvoryakovskaya, Ksenia Isaeva, Aleksandra Chomakhidze, Evgeniya Chistyakova, Olga Lomakina, Rina Denisova, Anna Mamutova, Anna Fetisova, Marina Gautier, Dariya Vankova, Ivan Kriulin, Ruslan Saygitov
Background: A significant number of systemic juvenile idiopathic arthritis (sJIA) patients discontinue biologic disease-modifying antirheumatic drugs (DMARDs) due to lack of efficacy or safety concerns. Studies of biologic therapy switch regimens in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::372f049709695752eae6fb0f4510ac42
https://doi.org/10.21203/rs.3.rs-1174736/v1
https://doi.org/10.21203/rs.3.rs-1174736/v1
